Yuan, Jun http://orcid.org/0000-0001-6542-4654
Pedrini, Steve
Thota, Rohith
Doecke, James http://orcid.org/0000-0003-2863-0293
Chatterjee, Pratishtha http://orcid.org/0000-0003-4877-1958
Sohrabi, Hamid R.
Teunissen, Charlotte E.
Verberk, Inge M. W. http://orcid.org/0000-0003-0341-7445
Stoops, Erik
Vanderstichele, Hugo
Meloni, Bruno P.
Mitchell, Christopher
Rainey-Smith, Stephanie
Goozee, Kathryn http://orcid.org/0000-0002-3573-1554
Tai, Andrew Chi Pang
Ashton, Nicholas
Zetterberg, Henrik
Blennow, Kaj http://orcid.org/0000-0002-1890-4193
Gao, Junjie
Liu, Delin
Mastaglia, Frank
Inderjeeth, Charles
Zheng, Minghao http://orcid.org/0000-0003-1185-4768
Martins, Ralph N.
Article History
Received: 22 February 2023
Accepted: 7 June 2023
First Online: 4 September 2023
Competing interests
: K.B. has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, BioArctic, Biogen, JOMDD/Shimadzu. Julius Clinical, Lilly, MagQu, Novartis, Ono Pharma, Pharmatrophix, Prothena, Roche Diagnostics, and Siemens Healthineers, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, outside the work presented in this paper. H.Z. has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Passage Bio, Pinteon Therapeutics, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). C.T. has a collaboration contract with ADx Neurosciences, Quanterix and Eli Lilly, performed contract research or received grants from AC-Immune, Axon Neurosciences, BioConnect, Bioorchestra, Brainstorm Therapeutics, Celgene, EIP Pharma, Eisai, Fujirebio, Grifols, Instant Nano Biosensors, Merck, Novo Nordisk, PeopleBio, Roche, Siemens, Toyama, Vivoryon. She had speaker contracts for Roche, Grifols, Novo Nordisk. She serves on editorial boards of Medidact Neurologie/Springer, Alzheimer Research and Therapy, Neurology: Neuroimmunology & Neuroinflammation. E.S. is an employee of ADx NeuroSciences. H.V. was a co-founder of ADx NeuroSciences. All other authors report no conflict of interest in relation to the current study.